We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBP icon
3076
Corbus Pharmaceuticals
CRBP
$189M
$7K ﹤0.01%
2,225
-236
-10% -$908
ADNWW
3077
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$6K ﹤0.01%
38,500
APPH
3078
DELISTED
AppHarvest, Inc. Common Stock
APPH
$6K ﹤0.01%
11,226
-5,642
-33% -$7.35K
PRTY
3079
DELISTED
Party City Holdco Inc.
PRTY
$6K ﹤0.01%
16,832
+500
+3% +$502
OIG
3080
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$5K ﹤0.01%
687
-50
-7% -$574
STAB
3081
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$5K ﹤0.01%
59,825
-9,000
-13% -$1.14K
FEED
3082
ENvue Medical Inc
FEED
$3.79M
$4K ﹤0.01%
7
VERO
3083
DELISTED
Venus Concept
VERO
$4K ﹤0.01%
68
VSTM icon
3084
Verastem
VSTM
$629M
$4K ﹤0.01%
871
ACGN
3085
DELISTED
Aceragen Inc
ACGN
$4K ﹤0.01%
+636
New +$3.81K
ANY icon
3086
Sphere 3D
ANY
$18.3M
$3K ﹤0.01%
179
-33
-16% -$861
VTGN icon
3087
VistaGen Therapeutics
VTGN
$11.6M
$3K ﹤0.01%
891
+540
+154% +$2.03K
SIEN
3088
DELISTED
Sientra, Inc.
SIEN
$3K ﹤0.01%
1,489
NXTP
3089
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$2K ﹤0.01%
750
GMBL
3090
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$2K ﹤0.01%
1
SFT
3091
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$2K ﹤0.01%
+1,374
New +$5.22K
TALKW
3092
DELISTED
Talkspace Inc Warrant
TALKW
$1K ﹤0.01%
10,550
REED
3093
DELISTED
Reeds, Inc. Common Stock
REED
$1K ﹤0.01%
+214
New +$1.2K
AEI icon
3094
Alset
AEI
$43.6M
-550
Closed -$3K
AGO icon
3095
Assured Guaranty
AGO
$3.29B
-4,263
Closed -$207K
AI icon
3096
C3.ai
AI
$1.57B
-10,962
Closed -$137K
AIZ icon
3097
Assurant
AIZ
$13.9B
-2,564
Closed -$372K
ALLE icon
3098
Allegion
ALLE
$14.1B
-2,721
Closed -$244K
AMBP icon
3099
Ardagh Metal Packaging
AMBP
$3.02B
-12,564
Closed -$61K
AMED
3100
DELISTED
Amedisys
AMED
-2,944
Closed -$285K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.